Panel Discussion: Accelerating Scalable & Cost-Effective Extra-Cellular Vesicle Manufacturing for the Development of Therapeutics for Regenerative, Precision & CGT Therapies
Time: 11:30 am
day: Conference Day Two
Details:
- Exploring cost-efficient exosome sources such as bodily fluids to reduce the high production costs associated with cellderived exosomes
- Understanding the complexities involved in setting up pipelines for the purification and production of engineered exosomes to optimize cost considerations throughout the development process
- Delving into the factors contributing to the cost of engineered exosomes, including production methods and regulatory compliance, for strategic planning to manage expenses effectively
